In September 2020, Eswatini became the first country in Africa to achieve the United Nations HIV targets with 96% of people living with HIV aware of their status, 94% on antiretroviral therapy (ART), and 91% virally suppressed. The imminence of these milestones placed sustained epidemic control firmly in the nation’s reach, and strategies had to evolve accordingly. The Eswatini HIV Prevention and Clinical Services (EHPCS) project served to foster epidemic control by addressing the remaining barriers to prevention and treatment continuity. This required the use of technically sound, coordinated approaches that were linked high-level objectives and complimented national strategic plans.
Explore Related Resources
Resource
Protecting Lives, Sustaining Progress
Published March 2026
The following landscape analysis of maternal and child health, HIV prevention, diagnosis, and treatment, and the historic strength of U.S. leadership in global aid provides an overview of these key areas of global health and recommendations for U.S. Congressional engagement and prioritization.
View Resource
Topics:
Advocacy,
Children,
Global Health Security,
Health System Strengthening,
HIV,
Maternal and Child Health,
Mothers and Infants,
Women
Child,Precious Ogweno accompanied by caregiver Leah Ogweno, at the TB clinic -HEI in Mbita sub county hospital, Mbita, Homabay. Photo by Kevin Ouma for EGPAF.
Journal Articles
Tuberculosis Preventive Treatment Uptake Among Patients Initiating Antiretroviral Therapy in Malawi: Children Left Behind
Published November 2025
Background: Tuberculosis preventive treatment (TPT) is recommended for people living with HIV (PLHIV) to reduce the tuberculosis (TB) incidence in regions with a high prevalence of TB. We evaluated the uptake and completion of TPT among newly initiated antiretroviral therapy (ART) patients in a programme setting in Malawi. Objectives: To describe TPT initiation and completion rates, and […]
View Resource
Topics:
Pediatric Tuberculosis (TB),
Tuberculosis (TB)
Countries:
Malawi
Journal Articles
Birth Defects and Adverse Pregnancy Outcomes in Hospital-based Birth Surveillance in Eswatini
Published February 2025
Background The Botswana Tsepamo study identified an initial neural tube defect (NTD) safety signal with dolutegravir antiretroviral therapy (ART) exposure at conception. We conducted similar surveillance in 5 hospitals in Eswatini from September 2021 to September 2023 to evaluate the prevalence of birth defects and adverse pregnancy outcomes by maternal HIV status and ART regimen/timing. […]
View Resource
Countries:
Eswatini